GI Innovation, Inc. Stock

Equities

A358570

KR7358570000

Biotechnology & Medical Research

End-of-day quote Korea S.E. 06:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
12,890 KRW +3.95% Intraday chart for GI Innovation, Inc. +0.31% +6.97%
Sales 2023 * 13B 9.46M Sales 2024 * 198B 144M Capitalization 547B 398M
Net income 2023 * -72B -52.42M Net income 2024 * 107B 77.9M EV / Sales 2023 * 42.1 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 2.76 x
P/E ratio 2023 *
-7.53 x
P/E ratio 2024 *
5.09 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 88.78%
More Fundamentals * Assessed data
Dynamic Chart
1 day-3.58%
1 week-3.50%
Current month-6.13%
1 month+1.97%
3 months+6.67%
6 months+8.77%
Current year+2.90%
More quotes
1 week
12 390.00
Extreme 12390
13 460.00
1 month
12 000.00
Extreme 12000
14 650.00
Current year
9 810.00
Extreme 9810
14 650.00
1 year
8 080.00
Extreme 8080
15 700.00
3 years
8 080.00
Extreme 8080
15 700.00
5 years
8 080.00
Extreme 8080
15 700.00
10 years
8 080.00
Extreme 8080
15 700.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 -
Chief Executive Officer 67 22-03-03
Director of Finance/CFO 42 17-08-31
Members of the board TitleAgeSince
Chief Executive Officer 67 22-03-03
President 58 18-11-30
Director/Board Member 49 22-02-28
More insiders
Date Price Change Volume
24-04-17 12,890 +3.95% 413 982
24-04-17 12,400 -3.58% 382,894
24-04-16 12,860 -0.23% 497,785
24-04-15 12,890 -2.79% 363,627
24-04-12 13,260 +1.77% 338,326

End-of-day quote Korea S.E., April 16, 2024

More quotes
GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
12,400 KRW
Average target price
21,500 KRW
Spread / Average Target
+73.39%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A358570 Stock